GenMark Diagnostics Inc. Daily Stock Analysis

Daily Stock Analysis, GNMK, GenMark Diagnostics Inc, priceseries

GenMark Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
24.04
Close
24.04
High
24.06
Low
24.03
Previous Close
24.04
Daily Price Gain
0.00
YTD High
24.25
YTD High Date
Mar 26, 2021
YTD Low
12.76
YTD Low Date
Jan 29, 2021
YTD Price Change
8.92
YTD Gain
58.99%
52 Week High
24.25
52 Week High Date
Mar 26, 2021
52 Week Low
12.32
52 Week Low Date
Dec 14, 2020
52 Week Price Change
11.08
52 Week Gain
85.49%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 24. 2017
11.25
Mar 28. 2017
12.67
22 Trading Days
12.65%
Link
LONG
Jan 8. 2018
5.16
Jan 9. 2018
5.49
1 Trading Days
6.44%
Link
LONG
Jan 19. 2018
4.83
Jan 30. 2018
5.38
7 Trading Days
11.46%
Link
LONG
Apr 13. 2018
5.45
Apr 30. 2018
6.26
11 Trading Days
14.91%
Link
LONG
Jul 31. 2018
6.68
Aug 23. 2018
7.15
17 Trading Days
7.03%
Link
LONG
Dec 26. 2018
4.39
Jan 23. 2019
5.74
18 Trading Days
30.76%
Link
LONG
Feb 20. 2019
6.73
Mar 5. 2019
7.41
9 Trading Days
10.10%
Link
LONG
Mar 10. 2020
4.75
Mar 13. 2020
5.06
3 Trading Days
6.58%
Link
LONG
Apr 8. 2020
6.04
May 6. 2020
10.75
19 Trading Days
77.92%
Link
LONG
Jun 10. 2020
9.67
Jul 24. 2020
17.22
31 Trading Days
78.10%
Link
LONG
Oct 6. 2020
14.14
Oct 9. 2020
14.95
3 Trading Days
5.69%
Link
LONG
Feb 5. 2021
14.67
Feb 22. 2021
19.95
10 Trading Days
35.98%
Link
Company Information
Stock Symbol
GNMK
Exchange
NasdaqGM
Company URL
http://www.genmarkdx.com
Company Phone
(760) 448-4300
CEO
Hany Massarany
Headquarters
California
Business Address
5964 LA PLACE COURT, CARLSBAD, CA 92008
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001487371
About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The firm focuses on the development and commercializing of its its proprietary eSensor detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Description

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. The company provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test, as well as HCV genotyping test and associated custom manufactured reagents, and 2C19 genotyping test. The company also provides ePlex instrument and RP panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading